A-K Budde

Publications (1)8.3 Total impact

• Article: In-vivo detectable antibodies directed against the oncofetal antigen/immature laminin receptor can recognize and control myeloma cells--clinical implications.

  S Siegel, B Friedrichs, A-K Budde, A Barsoum, J Coggin, M Tiemann, D Kabelitz, M Zeis
  Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 06/2008; 22(11):2115-8. · 8.30 Impact Factor